Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement

Michael B Streiff, Peggy S. Kraus, Peter Pronovost

Research output: Contribution to journalArticle

Abstract

Warfarin is prescribed to millions of Americans for the management of thromboembolism and is a common cause of adverse events. Optimizing warfarin therapy has been the focus of national quality improvement initiatives. Anticoagulation clinics have been demonstrated to result in better outcomes than usual care. Nevertheless, Highmark Medicare Services recently issued a provider bulletin on anticoagulation clinic visit reimbursement that we believe will adversely affect the care for patients on anticoagulation. In this commentary, we review the potential unintended consequences of this proposal and offer alternatives that we believe will increase the efficiency and quality of anticoagulation management.

Original languageEnglish (US)
Pages (from-to)733-736
Number of pages4
JournalAnnals of Pharmacotherapy
Volume44
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Warfarin
Medicare
Thromboembolism
Ambulatory Care
Quality Improvement
Patient Care
Therapeutics

Keywords

  • Anticoagulation
  • Anticoagulation clinic
  • Center for Medicare
  • Health-care economics
  • Medicaid Services
  • Warfarin

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement. / Streiff, Michael B; Kraus, Peggy S.; Pronovost, Peter.

In: Annals of Pharmacotherapy, Vol. 44, No. 4, 04.2010, p. 733-736.

Research output: Contribution to journalArticle

@article{2ca798ce326a455caa84d1f8f80bedb9,
title = "Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement",
abstract = "Warfarin is prescribed to millions of Americans for the management of thromboembolism and is a common cause of adverse events. Optimizing warfarin therapy has been the focus of national quality improvement initiatives. Anticoagulation clinics have been demonstrated to result in better outcomes than usual care. Nevertheless, Highmark Medicare Services recently issued a provider bulletin on anticoagulation clinic visit reimbursement that we believe will adversely affect the care for patients on anticoagulation. In this commentary, we review the potential unintended consequences of this proposal and offer alternatives that we believe will increase the efficiency and quality of anticoagulation management.",
keywords = "Anticoagulation, Anticoagulation clinic, Center for Medicare, Health-care economics, Medicaid Services, Warfarin",
author = "Streiff, {Michael B} and Kraus, {Peggy S.} and Peter Pronovost",
year = "2010",
month = "4",
doi = "10.1345/aph.1M666",
language = "English (US)",
volume = "44",
pages = "733--736",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "4",

}

TY - JOUR

T1 - Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement

AU - Streiff, Michael B

AU - Kraus, Peggy S.

AU - Pronovost, Peter

PY - 2010/4

Y1 - 2010/4

N2 - Warfarin is prescribed to millions of Americans for the management of thromboembolism and is a common cause of adverse events. Optimizing warfarin therapy has been the focus of national quality improvement initiatives. Anticoagulation clinics have been demonstrated to result in better outcomes than usual care. Nevertheless, Highmark Medicare Services recently issued a provider bulletin on anticoagulation clinic visit reimbursement that we believe will adversely affect the care for patients on anticoagulation. In this commentary, we review the potential unintended consequences of this proposal and offer alternatives that we believe will increase the efficiency and quality of anticoagulation management.

AB - Warfarin is prescribed to millions of Americans for the management of thromboembolism and is a common cause of adverse events. Optimizing warfarin therapy has been the focus of national quality improvement initiatives. Anticoagulation clinics have been demonstrated to result in better outcomes than usual care. Nevertheless, Highmark Medicare Services recently issued a provider bulletin on anticoagulation clinic visit reimbursement that we believe will adversely affect the care for patients on anticoagulation. In this commentary, we review the potential unintended consequences of this proposal and offer alternatives that we believe will increase the efficiency and quality of anticoagulation management.

KW - Anticoagulation

KW - Anticoagulation clinic

KW - Center for Medicare

KW - Health-care economics

KW - Medicaid Services

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=77950606063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950606063&partnerID=8YFLogxK

U2 - 10.1345/aph.1M666

DO - 10.1345/aph.1M666

M3 - Article

C2 - 20332336

AN - SCOPUS:77950606063

VL - 44

SP - 733

EP - 736

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 4

ER -